Autologous adipose-derived mesenchymal stem cell therapy (Celltex)

自体脂肪来源的间充质干细胞疗法

Report date: 2023/01/12 15:28:40

Base Information

Drug NameAutologous adipose-derived mesenchymal stem cell therapy (Celltex)

Drug Alias Nameautologous adult stem cell therapyadult adipose-derived autologous mesenchymal stem cell therapy

ClassificationCell and gene therapy > Cell therapy > Donor > AutologousCell and gene therapy > Cell therapy > Stem cell therapy > Mesenchymal stem cells therapyCell and gene therapy > Cell therapy > Source of cells > Adipose-derived

Mechanisms of ActionStem cell replacements

TargetsNot applicable

Therapy Area/IndicationsOsteoarthritis, KneeOsteoarthritis, HipOsteoarthritis

Global Approved IndicationsN/A

Approved Indications in ChinaN/A

Original Approved Country/TerritoryN/A

Original Approved DateN/A

Country/TerritoryUnited States

CombinationsNo

Global Highest StatusPhase 2 Clinical

Highest Status in ChinaN/A

Originator CompaniesCelltex Therapeutics Co

China Registration ClassN/A

Develop Information

Active CompaniesCelltex Therapeutics Co

Inactive CompaniesN/A

Active IndicationsOsteoarthritis, KneeOsteoarthritis, HipOsteoarthritis

Inactive IndicationsN/A

Other Information

ATC CodeN/A